Mongolia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients
Condition:   Asthma Interventions:   Drug: Budesonide 200 microgram/Puff, HFA MDI;   Drug: Budesonide 100 microgram/Actuation Powder for Inhalation Sponsors:   Intech Biopharm Ltd.;   GCP ClinPlus Co., Ltd.;   Beijing Aicomer Pharmaceutical Technology Co., Ltd.;   Key Tech;   Healthcare Inc;   Peking University People's Hospital;   Beijing Friendship Hospital;   Tianjin First Central Hospital;   Bao Gang Hospital;   The Affili ated Hospital of Inner Mongolia Medical University;   Beijing Yi Hua Hospital Management Co., Ltd;   The Second Hospital of Hebei Medical University; ...
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials